User:Mandy Bechman/Sandbox 1: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
== Disease == | == Disease == | ||
===Tirzepatide=== | ===Tirzepatide=== | ||
One of the most promising treatments to GIP malfunction is <scene name='10/1038867/Tirzepatide/2'>Tirzepatide</scene>. | One of the most promising treatments to GIP malfunction is <scene name='10/1038867/Tirzepatide/2'>Tirzepatide</scene>, also known as Mounharo, created by Eli Lily. It is an antidiabetic as well as weight loss drug. The structure of Tirzepatide functions as an incretin receptor agonist to GIP by activating GIP's receptor and producing insulin. | ||
[[Image:Sequence.png|400 px|left|thumb|Sequence comparison of the first 28 residues of GIP and Tirzepatide.]] | [[Image:Sequence.png|400 px|left|thumb|Sequence comparison of the first 28 residues of GIP and Tirzepatide.]] | ||
